[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
From the Archives of the Archives
July 2007

A look at the past. . .

Arch Ophthalmol. 2007;125(7):994. doi:10.1001/archopht.125.7.994-a

The local clinical use of a 30 per cent solution of sodium sulfacetimide was first reported by Dickson. Under the auspices of the Ross Foundation for the Prevention of Blindness, in a trial period of six months, of 11,953 cases of ocular injuries, there were only 7 instances of corneal ulcer, while before the use of this drug 350 cases of corneal ulcer occurred in a three year period. Thus the preventive value is obvious.

Reference: Mayer LL. Sodium sulfacetimide in ophthalmology. Arch Ophthalmol. 1948;39(2):232-235.